Etiology and management of dyslipidemia in children with chronic kidney disease and end-stage renal disease.

about

Cardiovascular risks in chronic kidney disease pediatric patients.Improving long-term outcomes after pediatric renal transplantation by addressing dyslipidemia.

P2860

Q47112805-69BE9279-82AF-4DBD-B5E9-A05CDAC44E05 Q48330750-763602C3-C3DF-431C-9370-CEEE1830466F

P2860

Etiology and management of dyslipidemia in children with chronic kidney disease and end-stage renal disease.

Item

http://www.wikidata.org/entity/Q38388185

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Etiology and management of dys ...... e and end-stage renal disease.

@en

type

Item

label

Etiology and management of dys ...... e and end-stage renal disease.

@en

prefLabel

Etiology and management of dys ...... e and end-stage renal disease.

@en

P1476

Etiology and management of dys ...... e and end-stage renal disease.

@en

P2093

Douglas M Silverstein

http://www.w3.org/2001/XMLSchema#string

Mona Khurana

http://www.w3.org/2001/XMLSchema#string

P2860

Cloning and sequencing of human cholesteryl ester transfer protein cDNA

Cardiovascular risk reduction in high-risk pediatric patients: a scientific statement from the American Heart Association Expert Panel on Population and Prevention Science; the Councils on Cardiovascular Disease in the Young, Epidemiology and Preven

Effects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomised controlled trials

Phase III trial of Rapamune versus placebo in primary renal allograft recipients.

Cyclosporine and tacrolimus (FK506): a comparison of efficacy and safety profiles.

Insulin resistance and lipid metabolism.

Circulating angiopoietin-like 4 links proteinuria with hypertriglyceridemia in nephrotic syndrome.

Rosuvastatin and cardiovascular events in patients undergoing hemodialysis.

Serum lipid and lipoprotein alterations in nephrosis

Rosuvastatin for primary prevention in older persons with elevated C-reactive protein and low to average low-density lipoprotein cholesterol levels: exploratory analysis of a randomized trial.

P2888

s00467-015-3075-9

P304

2073-2084

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00467-015-3075-9

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-03-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

274086452

http://www.w3.org/2001/XMLSchema#string

P6179

1038621522

http://www.w3.org/2001/XMLSchema#string

P698

25801207

http://www.w3.org/2001/XMLSchema#string

P921

dyslipidemias

Etiology and management of dyslipidemia in children with chronic kidney disease and end-stage renal disease.

about

P2860

P2860

Etiology and management of dyslipidemia in children with chronic kidney disease and end-stage renal disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P5875

P6179

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P5875

P6179

P698

P921